سعر راسيكاريا 100مجم 20 كبسولة 2026
Racecarrhea 100mg 20 caps- المادة الفعالة: Racecadotril
- EGPI
- عن طريق الفم
الفئة: مضاد للإسهال
معلومات الدواء
التفاصيل الكاملةعن الدواءAbout the medicine
Racecadotril 100 mg capsule, an intestinal antisecretory (enkephalinase inhibitor) antidiarrhoeal; 20 capsules (2 strips).
Racecadotril 100 mg capsule, an intestinal antisecretory (enkephalinase inhibitor) antidiarrhoeal; 20 capsules (2 strips).
دواعي الاستعمالUses
- Symptomatic treatment of acute diarrhoea in adults when causal treatment is not possible (or as complementary treatment)الفئة: AdultsHealth Products Regulatory Authority (HPRA)
- Symptomatic treatment of acute diarrhoea in adults when causal treatment is not possible (or as complementary treatment)Population: AdultsHealth Products Regulatory Authority (HPRA)
الآثار الجانبيةSide effects
- Common: headache. Uncommon: rash, erythema. Frequency unknown: erythema multiforme, angioedema and facial/lip/tongue/eyelid oedema, urticaria, pruritus, DRESS, anaphylactic shock.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Common: headache. Uncommon: rash, erythema. Frequency unknown: erythema multiforme, angioedema and facial/lip/tongue/eyelid oedema, urticaria, pruritus, DRESS, anaphylactic shock.International label, same formulation · Health Products Regulatory Authority (HPRA)
موانع الاستعمالContraindications
- Hypersensitivity to racecadotril or any excipient.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Hypersensitivity to racecadotril or any excipient.International label, same formulation · Health Products Regulatory Authority (HPRA)
تحذيرات واحتياطاتWarnings & precautions
- Racecadotril does not modify usual rehydration regimens; rehydration remains essential.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Do not use with bloody or purulent stools and fever (possible invasive bacterial infection) or in antibiotic-associated diarrhoea; chronic diarrhoea not sufficiently studied.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Angioedema (allergic or bradykinin-mediated) may occur; stop treatment, supervise until resolution and do not reintroduce. Careful risk/benefit assessment needed with ACE inhibitors.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Racecadotril does not modify usual rehydration regimens; rehydration remains essential.International label, same formulation · Health Products Regulatory Authority (HPRA)
- Do not use with bloody or purulent stools and fever (possible invasive bacterial infection) or in antibiotic-associated diarrhoea; chronic diarrhoea not sufficiently studied.International label, same formulation · Health Products Regulatory Authority (HPRA)
- Angioedema (allergic or bradykinin-mediated) may occur; stop treatment, supervise until resolution and do not reintroduce. Careful risk/benefit assessment needed with ACE inhibitors.International label, same formulation · Health Products Regulatory Authority (HPRA)
التداخلات الدوائيةDrug interactions
- ACE inhibitors and other drugs causing bradykinin-mediated angioedema (e.g. angiotensin II antagonists, gliptins, mTOR inhibitors, sacubitril)Concomitant use may increase the risk of angioedema and is not recommended.Health Products Regulatory Authority (HPRA)
- ACE inhibitors and other drugs causing bradykinin-mediated angioedema (e.g. angiotensin II antagonists, gliptins, mTOR inhibitors, sacubitril)Concomitant use may increase the risk of angioedema and is not recommended.Health Products Regulatory Authority (HPRA)
الحمل والرضاعةPregnancy & breastfeeding
- No adequate human data; animal studies show no harmful effects, but racecadotril should not be given to pregnant women.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- Excretion in human milk unknown; should not be given to breastfeeding women.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA)
- No adequate human data; animal studies show no harmful effects, but racecadotril should not be given to pregnant women.International label, same formulation · Health Products Regulatory Authority (HPRA)
- Excretion in human milk unknown; should not be given to breastfeeding women.International label, same formulation · Health Products Regulatory Authority (HPRA)
المثائل (2)
كل المثائل والبدائلنفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.
| الدواء | السعر | الفرق عن الأصلي |
|---|---|---|
| راسيكاسك 100 مجم 10 كبسولةRacecasec 100 mg 10 capsBorg · 100 mgالأرخص | السعر48ج.م4.8ج.م للوحدة | الفرق عن الأصليأرخص 68ج.م (58.6%) |
| هيدراسيك 100مجم 10 كبسولاتHidrasec 100 mg capsulesAbbott Laboratories · كبسولات صلبة · 100 mg | السعر109ج.م10.9ج.م للوحدة | الفرق عن الأصليأرخص 7ج.م (6%) |
تاريخ السعر
تغيّر السعر الرسمي: من 78 إلى 116 ج.م، 2 أسعار مسجلة
| التاريخ | السعر (ج.م) |
|---|---|
| سعر سابق بدون تاريخ | 78 |
| 116 |
| التاريخ | من | إلى | التغيير |
|---|---|---|---|
| 78ج.م | 116ج.م | زيادة 48.7% |
المعرّفات
- تصنيف ATC
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من EGPI
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- Health Products Regulatory Authority (HPRA)
- WHO Collaborating Centre for Drug Statistics Methodology
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا